Table 1. Sample summary before and after quality control (QC).
African American | European American | |||||
Characteristic | All samplesbefore QC | Discovery setafter QC | Replication setafter QC | All Samples after QC | Replication set before QC | Replication set after QC |
Cases | 1487 | 818 | 455 | 1273 | 518 | 442 |
Controls | 1504 | 908 | 577 | 1465 | 379 | 339 |
External Controls | 180a | 180 | 0 | 180 | 3208b | 1945 |
Unknown Affection Status | 2 | 0 | 0 | 0 | 0 | 0 |
Male | 889 | 575 | 244 | 819 | 1847 | 1173 |
Female | 2264 | 1331 | 768 | 2099 | 2247 | 1553 |
Unknown Gender | 20 | 0 | 0 | 0 | 11 | 0 |
Total | 3173 | 1906 | 1012 | 2918 | 4105 | 2726 |
Taken from the Illumina YRI-ASW iControlDB;
175 Caucasian healthy controls from the Illumina iControlDB, 1047 controls from the dbGaP GENEVA Melanoma study, and 1986 controls from the dbGAP CIDR: NGRC Parkinson’s Disease Study.